INTERCELLULAR TRANSFER OF GPI ANCHORED PROTEINS
GPI 锚定蛋白的细胞间转移
基本信息
- 批准号:6161920
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
GPI-anchored proteins are expressed on the plasma membranes of
eukaryotic cells. Their normal functions in humans range from the
regulation of embryogenesis and neurogenesis to protection from
complement-mediated cell destruction. Pathogenic processes involving
this class of proteins include disruption of cellular architecture
associated with carcinogenesis, parasitic infections, and
prion-associated diseases. Understanding the trafficking of GPI-anchored
proteins may lead to a further understanding of these diseases and the
development of novel therapies. We explored the trafficking of native
and recombinant GPI-proteins in mammalian cells. Native GPI-endocytotic
pathways were examined in hematopoietic cells. Using antibodies
specific for those cells and subsequent crosslinking those antibodies
with fluorescently labeled avidin we demonstrated efficient endocytosis
of such complexes in K562 erythroleukemia cells. We also tested the
hypothesis that clustering of all surface proteins including those
anchored by glycosylphosphatidylinositol can also efficiently activate
endocytosis. Recombinant CD4-GPI was expressed at very high levels on
human and rodent cell lines, and the direct and indirect intercellular
transfer of the protein was measured by fluorescence-based assays.
Membrane xenografting of the protein permitted syncytium formation with
HIV gp160 expressing cells. The production of competent and attenuated
HIV from those cells is currently being investigated. Based on these
experiments, we plan to continue the study of GPI-protein trafficking
in mammalian cells. Understanding the biology of native GPI-protein
expression should enhance our understanding of recombinant GPI-protein
expression in mammalian cells. The clinical applications are broad and
include gene therapy and vaccine development.
gpi锚定蛋白在细胞膜上表达
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J L MILLER其他文献
J L MILLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J L MILLER', 18)}}的其他基金
STABLE EXPRESSION OF TRANSFERRED NUCLEIC ACIDS IN MAMMALIAN CELLS
哺乳动物细胞中转移核酸的稳定表达
- 批准号:
6161921 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
- 批准号:
3810218 - 财政年份:
- 资助金额:
-- - 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE
针对人 CD4 分子的小鼠单克隆抗体
- 批准号:
3803662 - 财政年份:
- 资助金额:
-- - 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
- 批准号:
3814788 - 财政年份:
- 资助金额:
-- - 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
- 批准号:
3818867 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




